TrialClinics (Sao Paulo, Brazil)2023

Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.

Rosa M R Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.